This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,248.34 firm fixed-price contract is for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml, a medication used to treat diabetes. The contract has an ultimate completion date of January 18, 2024 and was awarded on January 17, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that...
This is a $2,337.33 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml to the DLA, which is responsible for the Medical Supply Chain. The contract has an ultimate completion date of May 30, 2024. While the original solicitation was not provided, this delivery order appears to be part of a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,843.71 contract is for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml, a specialty medication used for diabetes management. The contract has a firm fixed price and an ultimate completion date of January 8, 2025. This delivery order is associated with a larger Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $35,674.50, is for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml, a medication used in the management of diabetes. The contract has an ultimate completion date of February 10, 2025, and is a firm fixed-price contract. This contract is part of a larger Indefinite Delivery Contract (IDC) held...
This is a $10,429.97 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml, a medication used to treat diabetes. The contract has an ultimate completion date of April 17, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a $16,287.86 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml, a medication used for diabetes management. The award has an ultimate completion date of March 31, 2025 and was issued on March 28, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml medication. The contract has a firm fixed price of $11,347.56 and a completion date of January 15, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,879.98 firm fixed-price contract is for the delivery of Ozempic 1 mg/dose (4 mg/3 mL) 3 mL, a medication used to manage diabetes. The contract has an ultimate completion date of March 20, 2025 and was awarded on March 19, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,372.40 contract is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a medication used for diabetes management. The delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical to provide a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,342.41, is for the provision of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a medication used for diabetes management. The contract has a firm fixed price pricing type and an ultimate completion date of March 13, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC)...